These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2136959)

  • 1. 99mTc renal tubular function agents: current status.
    Eshima D; Fritzberg AR; Taylor A
    Semin Nucl Med; 1990 Jan; 20(1):28-40. PubMed ID: 2136959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
    Eshima D; Taylor A
    Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
    Moran JK
    Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
    Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
    Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.
    Eshima D; Taylor A; Fritzberg AR; Kasina S; Hansen L; Sorenson JF
    J Nucl Med; 1987 Jul; 28(7):1180-6. PubMed ID: 2955085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
    Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
    J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
    Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
    J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
    Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
    Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
    Kabasakal L
    Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-MAG3, a new renal imaging agent: preliminary results in patients.
    Taylor A; Eshima D; Alazraki N
    Eur J Nucl Med; 1987; 12(10):510-4. PubMed ID: 2952506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
    Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
    J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.